Granules India G N Prashanth resigns as Senior Vice President - Corporate Quality

Published On 2025-04-19 10:51 GMT   |   Update On 2025-04-19 10:51 GMT
Advertisement

Granules India has announced the resignation of G. N. Prashanth from the position of Senior Vice President - Corporate Quality of the Company due to personal reasons.

"G. N. Prashanth, shall cease to be the Senior Management Personnel (SMP) of the Company upon his resignation from the position of Senior Vice President- Corporate Quality with effect from the closure of business hours of April 18, 2025," Granules India stated in a BSE filing.

Read also: Granules India: Sethu Madhavan Sankaran resigns as Senior Vice President, Head- API Manufacturing, Operations

G. N. Prashanth is a postgraduate in pharmacy from Bangalore University and holds a graduate certification from IIMB. He has more than 30 years of experience and has worked in companies like Cipla, AstraZeneca, Orchid Chemicals and Pharmaceuticals, Neopharma, Kemwell, Microlabs, and Strides. He has experience in various functions like Quality Control, Analytical Development, Quality Assurance, Regulatory Affairs, and Project Management. He joined Granules in Oct 2019 as Senior Vice President and Head of Corporate Quality.

Read also: Granules India successfully closes acquisition of Swiss based CDMO Senn Chemicals

Granules India Limited, incorporated in 1991 is a vertically integrated Indian pharmaceutical company headquartered in Hyderabad. Amongst the few pharmaceutical companies in the world to be present across the manufacturing of the entire pharmaceutical value chain – from Active Pharmaceutical Ingredients (APIs), Pharmaceutical Formulation Intermediates (PFIs), and Finished Dosages (FDs), Granules products are distributed to over 300+ customers in regulated and semiregulated markets with a global presence extending to over 80+ countries with offices across India, US and UK. The Company has 10 manufacturing facilities out of which 8 are located in India and 2 are in the USA and has regulatory approvals from the US FDA, EDQM, EU GMP, COFEPRIS, WHO GMP, TGA, K FDA, DEA, MCC, and HALAL.

Read also: Granules India appoints Dr PN Baskaran as President - Head API Manufacturing, Operations

Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News